We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+4.72%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
AUM
$286M
AUM Growth
+$12.2M
Cap. Flow
+$9.03M
Cap. Flow %
3.16%
Top 10 Hldgs %
25.32%
Holding
644
New
52
Increased
128
Reduced
112
Closed
63

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.54M
2
TSLA icon
Tesla
TSLA
+$1.91M
3
CAT icon
Caterpillar
CAT
+$1.8M
4
VRNS icon
Varonis Systems
VRNS
+$1.09M
5
MU icon
Micron Technology
MU
+$842K

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.33%
2 Communication Services 14.54%
3 Technology 14.07%
4 Consumer Discretionary 11.03%
5 Healthcare 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
526
Bank of New York Mellon
BNY
$110B
$5K ﹤0.01%
94
-113
-55% -$5.95K
DVN icon
527
Devon Energy
DVN
$52.1B
$5K ﹤0.01%
136
FWONK icon
528
Liberty Media Series C
FWONK
$25.5B
$5K ﹤0.01%
138
IWS icon
529
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$5K ﹤0.01%
57
JBL icon
530
Jabil
JBL
$31.6B
$5K ﹤0.01%
179
LEA icon
531
Lear
LEA
$8.26B
$5K ﹤0.01%
35
-36
-51% -$6.16K
PLYA
532
DELISTED
Playa Hotels & Resorts
PLYA
$5K ﹤0.01%
500
PRU icon
533
Prudential Financial
PRU
$41.3B
$5K ﹤0.01%
47
SCHX icon
534
Schwab US Large- Cap ETF
SCHX
$74.3B
$5K ﹤0.01%
390
TEI
535
Templeton Emerging Markets Income Fund
TEI
$320M
$5K ﹤0.01%
500
URI icon
536
United Rentals
URI
$64.1B
$5K ﹤0.01%
32
ACAD icon
537
Acadia Pharmaceuticals
ACAD
$5.02B
$4K ﹤0.01%
200
IWP icon
538
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$4K ﹤0.01%
58
SCHA icon
539
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$4K ﹤0.01%
188
TLPH icon
540
Talphera
TLPH
$62.3M
$4K ﹤0.01%
50
YUMC icon
541
Yum China
YUMC
$15.3B
$4K ﹤0.01%
100
FLXN
542
DELISTED
Flexion Therapeutics, Inc.
FLXN
$4K ﹤0.01%
200
LEXEA
543
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$4K ﹤0.01%
95
COLL icon
544
Collegium Pharmaceutical
COLL
$786M
$3K ﹤0.01%
171
+57
+50% +$1.01K
FL
545
PUT
DELISTED
Foot Locker
FL
$3K ﹤0.01%
+68
New +$3.37K
HST icon
546
Host Hotels & Resorts
HST
$15.3B
$3K ﹤0.01%
155
JAZZ icon
547
Jazz Pharmaceuticals
JAZZ
$15.9B
$3K ﹤0.01%
16
KR icon
548
Kroger
KR
$35.4B
$3K ﹤0.01%
94
PJT icon
549
PJT Partners
PJT
$4.67B
$3K ﹤0.01%
50
EVHC
550
DELISTED
Envision Healthcare Holdings Inc
EVHC
$3K ﹤0.01%
55

Similar funds

Intellectus Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Intellectus Partners held 644 positions worth $286M, up 4.4% from $274M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Intellectus Partners deployed $9.03M of net new capital in Q3 2018, opening 52 new positions and adding to 128 existing holdings. Its largest new stake was OptimizeRx: 65,000 shares worth $1.17M.

By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 28% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was IBM, an estimated $1.07M trimmed.

  • Intellectus Partners's largest Q3 2018 buy was OptimizeRx: 65,000 shares worth $1.17M.
  • Intellectus Partners added most to Meta Platforms (Facebook) in Q3 2018, an estimated $2.54M increase.
  • Intellectus Partners's biggest Q3 2018 reduction was IBM, cutting an estimated $1.07M.
  • Intellectus Partners fully exited Accenture in Q3 2018, selling an estimated $1.02M.
  • Intellectus Partners's ten largest holdings make up 25% of its $286M portfolio in Q3 2018.
  • Intellectus Partners opened 52 new positions and closed 63 in Q3 2018.
  • Intellectus Partners's portfolio value rose 4.4% quarter-over-quarter to $286M.

Based on Intellectus Partners's 13F filing for Q3 2018, filed 15 Nov 2018.